GlassScriptPhysician profile
Karen M Waskowicz
NPI 1114449576
$2,393.63
in general payments reported to CMS, 2019-2025
23 companies · $668 in 2025
The $668 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $398 · 2022: $603 · 2023: $382 · 2024: $343 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,293 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.49 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $481.99 | 2021-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $427.83 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $282.50 | 2022-2024 | Myrbetriq |
| Abbvie INC. | $185.96 | 2022-2025 | |
| Medtronic, INC. | $142.66 | 2023-2024 | Interstim |
| Travere Therapeutics, INC. | $110.83 | 2022 | |
| Ferring Pharmaceuticals INC. | $82.76 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $72.92 | 2025 | |
| Antares Pharma, INC. | $69.09 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $65.94 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.72 | 2024 | |
| Dendreon Pharmaceuticals LLC | $53.08 | 2022-2023 | Provenge |
| Amgen INC. | $51.99 | 2021-2022 | |
| Urogen Pharma, INC. | $42.34 | 2023-2025 | Jelmyto |
| Allergan, INC. | $39.45 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $38.49 | 2024-2025 | Imfinzi |
| Urovant Sciences INC | $37.50 | 2022 | |
| Procept Biorobotics Corporation | $35.62 | 2025 | |
| Laborie Medical Technologies Corp. | $32.65 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Evofem Biosciences, INC. | $24.45 | 2021 | |
| Axonics, INC. | $21.99 | 2024 | Bulkamid, Axonics |
| Endo USA, INC. | $18.31 | 2025 | Aveed, Xiaflex |
| Endo Pharmaceuticals INC. | $17.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Waskowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.